Bactobio's biotechnology creates a safer and greener world by evolving unculturable bacteria to become culturable in the lab. The company has built a library of novel bacterial species for downstream metabolite screening, enabling the discovery of drugs and treatment of diseases. Bactobio's platform aims to solve the antibiotic resistance crisis by discovering novel antibiotic classes targeting urgent bacterial pathogens. The company's technology has broad applications across the pharmaceutical, agricultural, and chemical industries. Bactobio has exclusive access to nature's untapped bioresource, allowing them to discover novel chemical and biological solutions.